Mandarin reaches first close on third China-Europe fund
China-Europe cross-border private equity firm Mandarin Capital Partners has reached a first close of EUR148 million ($163 million) on its third fund. The overall target is EUR250 million.
It includes contributions from new and existing Italian and international investors, as well as a significant GP commitment, according to a statement. A second close is expected in early 2020. Mandarin...
More on Greater China
Latest News
China data storage provider XSKY raises $45m
China-based data storage software services provider XSKY has raised a RMB320 million ($45 million) Series D led by China's State Owned Capital Venture Capital Fund.
China's CF PharmTech raises $50m Series F
CF PharmTech, a Chinese medical devices maker focused on innovative respiratory products, has raised a $50 million Series F round with support from CICC Capital.
China's Gan & Lee Pharmaceuticals gains after A-share debut
Chinese insulin manufacturer Gan & Lee Pharmaceuticals, which counts Qiming Venture Partners and Goldman Sachs among its investors, raised RMB2.5 billion ($354 million) through an A-share IPO.
KKR to buy control of Indian pharma player
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.